2022 HPTN Annual Meeting Presentations

State of the Network – Dr. Myron S. Cohen

An Exploration of Geographic Access to Substance Abuse Treatment Programs, Violence Against Women, and HIV Risk Behaviors – Dr. Noelle M. St. Vil

Alcohol Use and Sexual Risk Behavior in Young Women in Rural South Africa – Dr. Manuela Bullo

Intimate Partner Violence, Social Support, and Substance Use among Black men who have sex with men (BMSM) in the United States (HPTN 061) – Dr. Adedotun Ogunbajo

Examining Facilitators, Barriers, and Social Support in PrEP Uptake and Utilization for Young African Women: Implications for HIV Prevention – Dr. Ndidiamaka Amutah-Onukagha

Assessing the Impact of Case Manager Intervention Dosage on Viral Suppression among Men who have Sex with Men: Results from HPTN 078 – Donaldson F. Conserve

Thinking on Their Feet: Lessons Learnt from the Role, Identity, and Experiences of Community-Based HIV Service Providers in Delivering Universal Test and Treat Within the (PopART) Trial in Zambia and South Africa – Chiti Bwalya

Predictors of Participant Retention in a Community-Based HIV Prevention Cohort: Perspectives from the HPTN 071 (PopART) Study – Nomtha Bell-Mandla

Age and HIV Transmission: Insights from Phylogenetic Analysis – Dr. Kate Grabowski

HIV Infections in the Setting of Long-Acting Early Viral Suppression: the LEVI Syndrome – Dr. Susan Eshleman

Rapid Detection and Expansion of Omicron Variant in Southern Africa – Dr. Sikhulile Moyo

What Happened to HIV in 2020 and 2021? COVID-19 Impact on HIV Prevention and Treatment – Dr. Peter Ghys

What Happened to HIV in 2020 and 2021? COVID-19 Impact on HIV Prevention and Treatment – Dr. Demetre Daskalakis

Multipurpose Prevention Technologies and HPTN 104 – Dr. Lisa Haddad

mRNA Technology and HIV Vaccine Development – Dr. Mark Feinberg

COVID-19 Vaccines in People Living with HIV – Dr. Linda-Gail Bekker

COVID-19 Impact on Site Research – Dr. Nyaradzo Mgodi

Be Careful What You Ask For – Stepped Wedge Trials with TimeVarying Treatment Effects – Dr. Jim Hughes

Toward Better Practice of Covariate Adjustment in Analyzing Randomized Clinical Trials – Dr. Ting Ye

Population Impact of Expanding PrEP Coverage by Offering LongActing Injectable PrEP: Model Comparison Analysis – Dr. Dobromir Dimitrov